Harvest & Collection
PRODUCTS
-
The AMM-9862PSM is a compact, wideband gain block amplifier designed for high-performance RF applications.
-
At Mikart, our mission is to leverage our technical expertise in pharmaceutical development and manufacturing to deliver services that meet the diverse needs of our customers.
-
Whether you’re conducting an oncology trial, a neurology study, or imaging-based endpoint research, TrialKit’s flexible imaging capabilities can meet your needs.
-
Understanding the fine details of powder properties is crucial in the pharmaceutical industry, where the behavior of particulate matter can affect manufacturability and the efficacy of the final product.
-
At Körber, we have developed the Blister Expert (BE) so that you, as a pharmaceutical manufacturer, can deliver top quality in ever shorter production times. Thanks to its modular design, it covers a wide range of formats and can be quickly converted and cleaned. In short, a machine that adapts and meets all requirements.
WHITE PAPERS AND CASE STUDIES
-
How Easley Combined Utilities Cut Sludge Handling Costs By One-Third
Discover how a municipal wastewater treatment plant reduced its overall sludge management expenses by one-third and improved daily operational efficiency by implementing an advanced thickening system to streamline solids management and reduce hauling logistics.
-
Rapid Development Of A Liquid-Filled Capsule Formulation Of CBD
Discover how we developed and tested multiple oral formulations in just three months, identifying a top candidate that outperformed existing standards in key performance metrics.
-
Enhancing Data Capabilities For Greenville Water Utility
The Greenville Water Utility in Indiana is leveraging Qatium to enhance its water management and leak detection capabilities, significantly improving service efficiency.
-
WuXiHigh 2.0 Delivers A 180 mg/mL Formula
This case study shows how smart formulation and integrated development achieved a stable 180 mg/mL biologic for subcutaneous delivery, for teams tackling concentration issues.
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
Acoustic Inspection Helps Campbell River Optimize Inspection Program
In this case study, explore how incorporating the SL-RAT into their maintenance program has realized significant savings for the city of Campbell River.
-
Vaccine Fill Line Operations
Learn how adopting a harmonized, risk-based validation strategy across global sites can reduce operational readiness timelines and drive improvements in equipment effectiveness and regulatory compliance
-
How Optina Diagnostics Used EDC In Earlier Disease Detection
Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.
-
Optimizing Early-Stage Oncology
A strategic partnership enables a U.S. biotech company to address the struggles with their Phase I first-in-human oncology trial.
-
Timely Lab Data To Inform Outreach To Healthcare Professionals
Learn how you can leverage a system that offers flexible data delivery formats and seamless integration into commercialization workflows while also ensuring HIPAA-compliant deidentified data for patient privacy.
-
Bend Successfully Rescues Powder-Filled Capsule Program
Learn how to overcome tech transfer challenges and ensure consistent content uniformity by leveraging multidisciplinary expertise and decades of commercial encapsulation experience.
-
Re-Engineering A Complex Process For FDA Compliance
Discover the strategies that helped a company navigate a complex and shifting regulatory landscape to rapidly re-engineer a COVID-19 vaccine manufacturing process for FDA compliance.
NEWS
-
AEON Biopharma Appoints Industry Veteran Rob Bancroft As Chief Executive Officer4/21/2025
AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced today the appointment of Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft will also join AEON’s Board of Directors.
-
Consulta Remedios Selects Kevel's Retail Media Cloud To Power Its Next-Generation Advertising Platform5/2/2025
Kevel, the leading provider of API-based retail media ad serving technology, today announced that Consulta Remédios, Brazil's largest medicine price comparison platform, has selected Kevel's Retail Media Cloud to power the development and enhancement of its in-house retail media network.
-
Smarter Dentistry Starts Here: Muskan.AI Enhances Diagnostics, Imaging & Patient Care5/19/2025
Muskan.AI, a pioneer in the application of artificial intelligence to dentistry, has reached several key milestones in its mission to transform dental care through intelligent, accessible, and clinician-focused technology.
-
PulpFixin Announces Strategic Distribution Partnership With Wildcat Laboratory Solutions To Expand Sustainable Lab Products Across The UK And EU4/14/2025
PulpFixin, an innovator of sustainable laboratory products, announced today a new distribution partnership with Wildcat Laboratory Solutions a leading provider of lab equipment and solutions across the United Kingdom and European Union.
-
Agilitas Energy Expands Into Hydropower With Acquisition Of Two Projects In West Virginia And Maryland6/24/2025
Agilitas Energy, a leading developer and operator of renewable energy and energy storage systems, today announced the acquisition of two late-stage hydropower development projects from Advanced Hydro Solutions.
ABOUT
Harvest and Collection
Harvest and collection is the process used to retrieve biological agents and vaccines present in cell cultures or to harvest and collect stem cells from blood or bone marrow. Many bioresearch companies have sophisticated systems for harvesting and collecting cells. These systems make counting cells easier and they also protect against contamination.
Cells are harvested once the cells reach a density level in the cell culture medium that precludes further growth. The best time to harvest cells is when they are in a confluent state (at least 50% of the culture dish is covered and before 100% of the dish is covered).
Cells can be harvested using on of three methods: Mechanical, using Proteolytic enzymes, or using EDTA. Mechanical harvesting uses a rubber spatula to remove the cells from the growth surface or culture. This method is quick but can cause many cells to die because it is highly disruptive. This method is favored when harvesting lots of different samples of cells to prepare extracts.
In this case, viability of the cells doesn’t matter. Three enzymes; Trypsin, Collagenase, and Pronase can be used in combination with EDTA. The combination of these enzymes with the EDTA makes cells detach from the growth medium.
This method is easy but also has a downside. It can damage the cell surface by eating up exposed cell surface proteins. EDTA can be used alone to detach cells from their medium and it is gentler than using trypsin.
Normally, collected cells are placed in a new suspension, or growth medium to continue growing new cultures. This is referred to as passaging or splitting the cells.